TALIS BIOMEDICAL CORPORATION

Analyst Reco. Talis Biomedical Corporation

Equities

TLIS

US87424L2079

Market Closed - Nasdaq Other stock markets 02:00:00 01/05/2024 am IST			5-day change	1st Jan Change
8.62 ^USD	-4.96%		-4.33%	+15.70%

02/04	North American Morning Briefing : Stocks Seen -2-	DJ
28/03	Talis Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BTIG Adjusts Talis Biomedical's Price Target to $5 From $5.25, Keeps Sell Rating	16/23/16	MT
BTIG Downgrades Talis Biomedical to Sell From Neutral; Price Target is $1	18/22/18	MT
BofA Securities Adjusts Talis Biomedical's Price Target to $1.50 from $3, Keeps Underperform Rating	16/22/16	MT
BofA Securities Downgrades Talis Biomedical to Underperform From Neutral, Sets $3 Price Target	07/22/07	MT
TALIS BIOMEDICAL : JPMorgan Downgrades Talis Biomedical to Underweight From Neutral, Cuts Price Target to $7 from $10	27/21/27	MT
TALIS BIOMEDICAL : Piper Sandler Downgrades Talis Biomedical to Neutral From Overweight; Price Target is $9	12/21/12	MT
TALIS BIOMEDICAL : JPMorgan Lowers Talis Biomedical to Neutral From Overweight, Price Target to $10 From $17	11/21/11	MT
TALIS BIOMEDICAL : Piper Sandler Adjusts Talis Biomedical's Price Target to $13 From $17, Maintains Overweight Rating	12/21/12	MT
TALIS BIOMEDICAL : JPMorgan Initiates Talis Biomedical at Overweight With $18 Price Target	09/21/09	MT
TALIS BIOMEDICAL : BofA Securities Starts Talis Biomedical at Neutral With $14 Price Target	09/21/09	MT
TALIS BIOMEDICAL : BTIG Starts Talis Biomedical at Buy With $18 Price Target	09/21/09	MT
TALIS BIOMEDICAL : Piper Sandler Starts Talis Biomedical at Overweight With $17 Price Target	09/21/09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer